Illumina Inc (ILMN) - Product Pipeline Analysis, 2018 Update

1 of 5

FEATURED COMPANIES

  • Affymetrix, Inc.
  • Agilent Technologies Inc
  • GenMark Diagnostics Inc
  • Luminex Corp
  • Pacific Biosciences Inc
  • Qiagen NV
  • MORE
Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microarray kits and reagents; molecular biology reagents; and arrays and reagents. It offers human whole-genome sequencing; microarray services; and instrument services, training and consulting. Illumina caters its services to pharmaceutical companies, genomic research centers, academic institutions, biotechnology companies and clinical research organizations. The company sells its products through direct sales and distributors in the Americas, Asia-Pacific, Europe, the Middle East and Africa. Illumina is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Illumina Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Affymetrix, Inc.
  • Agilent Technologies Inc
  • GenMark Diagnostics Inc
  • Luminex Corp
  • Pacific Biosciences Inc
  • Qiagen NV
  • MORE
  • Illumina Inc Company Overview
  • Illumina Inc Company Snapshot
  • Illumina Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Illumina Inc - Pipeline Analysis Overview
  • Business Description
  • Illumina Inc - Key Facts
  • Illumina Inc - Major Products and Services
  • Illumina Inc Pipeline Products by Development Stage
  • Illumina Inc Ongoing Clinical Trials by Trial Status
  • Illumina Inc Pipeline Products Overview
  • Albumin Multiplex Assay
  • Albumin Multiplex Assay Product Overview
  • Companion Diagnostic Test - Oncology
  • Companion Diagnostic Test - Oncology Product Overview
  • Diagnostic Test - Nasopharyngeal Cancer
  • Diagnostic Test - Nasopharyngeal Cancer Product Overview
  • InfiniumDx CytoSNP-12 Assay
  • InfiniumDx CytoSNP-12 Assay Product Overview
  • Lab-On-A-Chip
  • Lab-On-A-Chip Product Overview
  • LSD-100 Lysosomal Storage Enzyme Analyzer
  • LSD-100 Lysosomal Storage Enzyme Analyzer Product Overview
  • MRSA Screening Test
  • MRSA Screening Test Product Overview
  • NGS Diagnostic System
  • NGS Diagnostic System Product Overview
  • NGS-Based Transplant Diagnostic Assay
  • NGS-Based Transplant Diagnostic Assay Product Overview
  • Pan-Cancer Screening Test
  • Pan-Cancer Screening Test Product Overview
  • Pan-Cancer Screening Test Clinical Trial
  • Point-Of-Care Diagnostic Device- HIV
  • Point-Of-Care Diagnostic Device- HIV Product Overview
  • Portable Benchtop Analyzer - Viral Load Assay
  • Portable Benchtop Analyzer - Viral Load Assay Product Overview
  • STAT-Seq Test
  • STAT-Seq Test Product Overview
  • TruSight Tumor 170
  • TruSight Tumor 170 Product Overview
  • Verifi Prenatal Test
  • Verifi Prenatal Test Product Overview
  • Verifi Prenatal Test Clinical Trial
  • Illumina Inc - Key Competitors
  • Illumina Inc - Key Employees
  • Illumina Inc - Key Employee Biographies
  • Illumina Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
  • Recent Developments
  • Illumina Inc, Recent Developments
  • May 09, 2018: ECRI Institute Reveals Important Differences in Prenatal Genetic Tests
  • May 07, 2018: Genome Medical Enters Employer Market with Diverse Genetic Health Programs and Wave of New Partners
  • Apr 24, 2018: Illumina Reports Financial Results for First Quarter of Fiscal Year 2018
  • Apr 16, 2018: Almac Diagnostics Validates Illumina TruSight Tumor 170 Cancer Mutation Panel for Prospective Testing in Clinical Trials
  • Mar 12, 2018: Illumina Names Dr. Phil Febbo Chief Medical Officer
  • Feb 12, 2018: New GUINNESS WORLD RECORDS Title Set for Fastest Genetic Diagnosis
  • Jan 30, 2018: Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2017
  • Jan 15, 2018: HCA Virginia Joins Sarah Cannon Early Breast Cancer Detection Study
  • Jan 08, 2018: Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology
  • Jan 08, 2018: Illumina Launches iSeq 100 Sequencing System
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • Illumina Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Illumina Inc Pipeline Products by Equipment Type
  • Illumina Inc Pipeline Products by Indication
  • Illumina Inc Ongoing Clinical Trials by Trial Status
  • Illumina Inc, Key Facts
  • Illumina Inc, Major Products and Services
  • Illumina Inc Number of Pipeline Products by Development Stage
  • Illumina Inc Pipeline Products Summary by Development Stage
  • Illumina Inc Ongoing Clinical Trials by Trial Status
  • Illumina Inc Ongoing Clinical Trials Summary
  • Albumin Multiplex Assay - Product Status
  • Albumin Multiplex Assay - Product Description
  • Companion Diagnostic Test - Oncology - Product Status
  • Companion Diagnostic Test - Oncology - Product Description
  • Diagnostic Test - Nasopharyngeal Cancer - Product Status
  • Diagnostic Test - Nasopharyngeal Cancer - Product Description
  • InfiniumDx CytoSNP-12 Assay - Product Status
  • InfiniumDx CytoSNP-12 Assay - Product Description
  • Lab-On-A-Chip - Product Status
  • Lab-On-A-Chip - Product Description
  • LSD-100 Lysosomal Storage Enzyme Analyzer - Product Status
  • LSD-100 Lysosomal Storage Enzyme Analyzer - Product Description
  • MRSA Screening Test - Product Status
  • MRSA Screening Test - Product Description
  • NGS Diagnostic System - Product Status
  • NGS Diagnostic System - Product Description
  • NGS-Based Transplant Diagnostic Assay - Product Status
  • NGS-Based Transplant Diagnostic Assay - Product Description
  • Pan-Cancer Screening Test - Product Status
  • Pan-Cancer Screening Test - Product Description
  • Pan-Cancer Screening Test - Breast Cancer Screening Cohort for the Development of Assays for Early Cancer Detection: The STRIVE Study
  • Pan-Cancer Screening Test - The Circulating Cell-free Genome Atlas Study
  • Point-Of-Care Diagnostic Device- HIV - Product Status
  • Point-Of-Care Diagnostic Device- HIV - Product Description
  • Portable Benchtop Analyzer - Viral Load Assay - Product Status
  • Portable Benchtop Analyzer - Viral Load Assay - Product Description
  • STAT-Seq Test - Product Status
  • STAT-Seq Test - Product Description
  • TruSight Tumor 170 - Product Status
  • TruSight Tumor 170 - Product Description
  • Verifi Prenatal Test - Product Status
  • Verifi Prenatal Test - Product Description
  • Verifi Prenatal Test - Prospective, Multi-center, Randomized Controlled Trial Comparing Pregnancy Outcomes Following Selection and Single Embryo Transfer (SET) Based on Preimplantation Genetic Screening (PGS) by Next Generation Sequencing (NGS) Versus Standard Morphological Assessment
  • Illumina Inc, Key Employees
  • Illumina Inc, Key Employee Biographies
  • Illumina Inc, Other Locations
  • Illumina Inc, Subsidiaries
  • Illumina Inc, Joint Venture
  • Glossary
List of Figures
  • Illumina Inc Pipeline Products by Equipment Type
  • Illumina Inc Pipeline Products by Development Stage
  • Illumina Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • GenMark Diagnostics Inc
  • Roche Diagnostics International Ltd
  • Thermo Fisher Scientific Inc
  • Pacific Biosciences Inc
  • Qiagen NV
  • Affymetrix, Inc.
  • Oxford Nanopore Technologies Ltd
  • Luminex Corp
  • Agilent Technologies Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll